Vir director granted RSUs and stock options
Vir Biotechnology, Inc. director Timothy Coughlin reported compensation-related equity grants.
Rhea-AI Filing Summary
Vir Biotechnology, Inc. director Timothy Coughlin reported compensation-related equity grants. He acquired two awards of 8,000 shares of common stock each at no cost, in the form of restricted stock units under the company’s Equity Incentive Plan. He also received two stock option grants covering 16,000 shares each at an exercise price of $8.51 per share, expiring in 2036. Portions of the RSUs and options begin vesting on June 9, 2027, with remaining amounts vesting over time or in full by the earlier of that date or the next annual meeting of stockholders. Following these grants, one reported common stock position shows 16,000 shares held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 48,000 shares
Grant/Award
4 txns
Insider
Coughlin Timothy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 16,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 16,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 8,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 8,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 32,000 contracts (Direct);
Common Stock — 16,000 shares (Direct)
Footnotes (5)
- F1. Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- F2. 1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.
- F3. The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
- F4. 1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.
- F5. The shares subject to the stock option vest and become exercisable in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Key Figures
RSU grant size 1: 8,000 shares
RSU grant size 2: 8,000 shares
Option grant size 1: 16,000 shares
+5 more
8 metrics
RSU grant size 1
8,000 shares
Restricted stock unit award of common stock
RSU grant size 2
8,000 shares
Second restricted stock unit award of common stock
Option grant size 1
16,000 shares
Stock option grant, right to buy common stock
Option grant size 2
16,000 shares
Second stock option grant, right to buy common stock
Option exercise price
$8.51 per share
Conversion or exercise price for stock options
Option expiration
June 8, 2036
Expiration date of stock option grants
Common shares after grant
16,000 shares
Total common stock held directly after one grant entry
Initial vesting date
June 9, 2027
First vesting date for RSUs and options
Key Terms
restricted stock units (RSUs), Equity Incentive Plan, stock option, vest, +1 more
5 terms
restricted stock units (RSUs) financial
"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Equity Incentive Plan financial
"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
stock option financial
"1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"The RSUs will vest in full on the earlier of June 9, 2027, or the date of the Issuer's next annual meeting of stockholders."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Vir Biotechnology (VIR) director Timothy Coughlin receive?
Timothy Coughlin received two restricted stock unit grants of 8,000 shares each and two stock option grants covering 16,000 shares each. All awards were granted at no cash cost as part of his director compensation.
What is the exercise price and expiration for Timothy Coughlin’s Vir (VIR) stock options?
Each stock option grant to Timothy Coughlin covers 16,000 shares at an exercise price of $8.51 per share. The options are scheduled to expire on June 8, 2036, if not exercised or otherwise terminated earlier.
How do Timothy Coughlin’s Vir (VIR) restricted stock units vest?
One RSU grant vests one-third on June 9, 2027, with the balance in two equal annual installments. Another RSU grant vests in full on the earlier of June 9, 2027, or Vir’s next annual meeting of stockholders.
How do Timothy Coughlin’s Vir (VIR) stock options vest over time?
One option grant vests one-third on June 9, 2027, with the remaining shares vesting in 24 equal monthly installments. Another option grant vests in full on the earlier of June 9, 2027, or Vir’s next annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
